Search results

Page results

• Increase in delirium, rare brain inflammation and stroke linked to COVID-19

  Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.

• Study reveals limitations of drug proposed for lung cancer treatment

  Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.

• Ward T16 North - Haematology

  T16 North is a specialist adult haematology inpatient ward dedicated to providing high-quality care for patients with a wide range of blood disorders.

• HSL update: Bordetella pertussis PCR testing

  Introduction of Bordetella pertussis PCR testing at Halo laboratory (Health Services Laboratories)

• Cystic fibrosis drug tested to fight inflammation in COVID-19

  Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.

• Navigating the exam period

  The psychology team at UCLH are running the next 'Navigating the exam period' group on Wednesday 19 February, from 1pm - 4pm.

• Hinge Knee Brace - Advice for Patients

  This information is for patients who have been given a hinge knee brace.

• New sickle cell pathway under UCLH@Home

  A new service to provide comprehensive care and support for patients living with Sickle Cell disorder is now available in the comfort of their homes thanks to a partnership between UCLH and Whittington Health NHS Trusts.

• Mixed sex accommodation and privacy

  Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay

• Walking Boot - Advice for Patients

  This information is for patients who have been given a walking boot, including air cast boots, pneumatic walking boots and vacoped boots.